Josephson’s Clinical Cardiac Electrophysiology: Techniques and Interpretations

Description:

Widely known as the premier electrophysiology text, Josephson’s Clinical Cardiac Electrophysiology provides a thorough understanding of the mechanisms of cardiac arrhythmias and the therapeutic interventions used to treat them. Dr. David J. Callans, personally chosen and trained by Dr. Mark Josephson, continues the tradition of excellence of previous editions while bringing the text fully up to date in every area of this complex field. The sixth edition provides highly visual guidance on the electrophysiologic methodology required to define the mechanism and site of origin of arrhythmia – enabling you to choose the safest and most effective therapy for each patient.

 

 

Enrich Your Digital Reading Experience

Read directly on your preferred device(s), such as computer, tablet, or smartphone.

Easily convert to audiobook, powering your content with natural language text-to-speech.

 

Table of Contents:

 

 

1.    Chapter 1 General Principles and Techniques of Electrophysiologic Investigation

2.    THE ELECTROPHYSIOLOGY LABORATORY

3.    Personnel

4.    INTRACARDIAC SIGNAL RECORDING AND INTERPRETATION

5.    Equipment

6.    CARDIAC CATHETERIZATION TECHNIQUE

7.    Right Atrium

8.    Left Atrium

9.    Right Ventricle

10.  Left Ventricle

11.  His Bundle Electrogram

12.  RISKS AND COMPLICATIONS

13.  Significant Hemorrhage

14.  Thromboembolism

15.  Phlebitis

16.  Arrhythmias

17.  Complications of Left Ventricular Studies

18.  Pericardial Effusion/Tamponade

19.  INTERPRETATION OF ELECTROPHYSIOLOGY STUDIES

20.  General Concepts

21.  MEASUREMENT OF CONDUCTION INTERVALS

22.  His Bundle Electrogram

23.  Assessment of “H”-V Interval

24.  Establishing Relationship of the His Bundle Deflection to Other Electrograms: Role of Catheter Position

25.  Simultaneous Left-Sided and Right-Sided Recordings

26.  His Bundle Pacing

27.  A-H Interval

28.  H-V Interval

29.  Intra-Atrial Conduction

30.  Intraventricular Conduction

31.  DESCRIPTION OF ELECTROGRAMS

32.  Descriptive Characteristics

33.  Quantitative Characteristics

34.  Left Ventricular Endocardial Activation

35.  PROGRAMMED STIMULATION

36.  Incremental Pacing

37.  Refractory Periods

38.  Patterns of Response to Atrial Extrastimuli

39.  Patterns of Response to Ventricular Extrastimuli

40.  Safety of Ventricular Stimulation

41.  Comparison of Antegrade and Retrograde Conduction

42.  Chapter 2 Sinus Node Function

43.  ELECTROCARDIOGRAPHIC FEATURES OF SINUS NODE DYSFUNCTION

44.  Sinus Bradycardia

45.  Sinoatrial Block and Sinus Arrest

46.  Bradycardia-Tachycardia Syndrome

47.  ELECTROCARDIOGRAPHIC MONITORING OF PATIENTS SUSPECTED OF HAVING SINUS NODE DYSFUNCTION

48.  ASSESSMENT OF AUTONOMIC TONE

49.  ELECTROPHYSIOLOGIC EVALUATION OF SINUS NODE FUNCTION

50.  Sinoatrial Conduction Time

51.  Sinus Node Electrogram

52.  Sinoatrial Conduction Time in Patients With Sick Sinus Syndrome

53.  Sinus Node Recovery Time

54.  Effect of Atropine and Autonomic Blockade on Sinus Node Recovery Time in Normal Persons

55.  Results of Sinus Node Testing in Patients Suspected of Having Sinus Node Dysfunction

56.  EFFECT OF DRUGS ON SINUS NODE RECOVERY TIME AND SINOATRIAL CONDUCTION TIME

57.  Digoxin

58.  Propranolol

59.  Calcium Channel Antagonists

60.  Antiarrhythmic Agents

61.  VAGAL HYPERSENSITIVITY (NEUROCIRCULATORY) SYNDROMES

62.  THERAPEUTIC IMPLICATIONS

63.  Chapter 3 Atrioventricular Conduction

64.  ATRIUM

65.  ATRIOVENTRICULAR NODE

66.  HIS BUNDLE

67.  INFRA-HIS CONDUCTION SYSTEM

68.  PAROXYSMAL A-V BLOCK

69.  VALUE OF INTRACARDIAC STUDIES IN THE EVALUATION OF A-V CONDUCTION DISTURBANCES

70.  SUPPRESSION OF A-V CONDUCTION BY VENTRICULAR STIMULATION

71.  THERAPEUTIC CONSIDERATIONS

72.  Chapter 4 Intraventricular Conduction Disturbances

73.  DEFINITIONS

74.  SITE OF “BLOCK” OR CONDUCTION DELAY DURING BUNDLE BRANCH BLOCK

75.  Chronic Right Bundle Branch Block

76.  Left Bundle Branch Block

77.  Transient Bundle Branch Block

78.  CLINICAL RELEVANCE OF INTRAVENTRICULAR CONDUCTION DISTURBANCES

79.  Role of Electrophysiologic Studies in Predicting Risk of Heart Block

80.  Methods to Identify Patients at Risk of Developing A-V Block

81.  Alternating Bundle Branch Block

82.  Syncope and Sudden Death in Patients With Bundle Branch Block

83.  THERAPEUTIC IMPLICATIONS

84.  Chapter 5 Miscellaneous Phenomena Related to Atrioventricular Conduction

85.  CONCEALED CONDUCTION

86.  GAP PHENOMENON

87.  SUPERNORMAL CONDUCTION

88.  Chapter 6 Ectopic Rhythms and Premature Depolarizations

89.  ATRIAL DEPOLARIZATIONS

90.  JUNCTIONAL (HIS BUNDLE OR A-V NODAL) DEPOLARIZATIONS

91.  FASCICULAR DEPOLARIZATIONS

92.  VENTRICULAR DEPOLARIZATIONS

93.  Chapter 7 Supraventricular Tachycardias

94.  MECHANISMS OF SUPRAVENTRICULAR TACHYCARDIA

95.  METHODS OF EVALUATION

96.  SUPRAVENTRICULAR TACHYCARDIA RESULTING FROM ATRIOVENTRICULAR NODAL REENTRY

97.  Mechanisms of Initiation of Atrioventricular Nodal Reentry

98.  Determinants for the Induction of Atrioventricular Nodal Reentry

99.  Atrial Activation Sequence and the P–QRS Relationship During Supraventricular Tachycardia

100.               Effect of Bundle Branch Block During Atrioventricular Nodal Reentrant Supraventricular Tachycardia

101.               Requirement of the Atrium and Ventricle

102.               SUPRAVENTRICULAR TACHYCARDIA RESULTING FROM CONCEALED ATRIOVENTRICULAR BYPASS TRACTS

103.               Mechanism of Initiation

104.               Effects of Pharmacologic and Physiologic Maneuvers During Supraventricular Tachycardia

105.               SUPRAVENTRICULAR TACHYCARDIA RESULTING FROM INTRA-ATRIAL OR SINUS NODE REENTRY

106.               AUTOMATIC ATRIAL TACHYCARDIA

107.               ATRIAL TACHYCARDIA DUE TO TRIGGERED ACTIVITY

108.               DISTINGUISHING ATRIAL TACHYCARDIA FROM AVNRT AND AVRT

109.               MULTIPLE SVT MECHANISMS IN INDIVIDUAL PATIENTS

110.               OVERVIEW

111.               Chapter 8 Atrial Fibrillation and Atrial Flutter

112.               ELECTROPHYSIOLOGIC AND ANATOMIC SUBSTRATES OF MACROREENTRANT ATRIAL TACHYCARDIA AND FIBRILLATION

113.               Conduction Defects in Patients With Atrial Fibrillation and Flutter

114.               Atrial Refractoriness

115.               Atrial Vulnerability

116.               Modern Studies of the Electrophysiologic and Anatomic Substrate of Atrial Fibrillation

117.               ELECTROPHYSIOLOGIC MECHANISMS OF ATRIAL FIBRILLATION

118.               Mapping During Atrial Fibrillation

119.               Stimulation During Atrial Fibrillation

120.               Relationship Between Atrial Flutter and Fibrillation

121.               ELECTROPHYSIOLOGIC MECHANISMS OF ATRIAL FLUTTER

122.               Induction of Atrial Flutter

123.               Characterization of the Reentrant Circuit in Atrial Flutter

124.               Termination of Atrial Flutter

125.               Effects of Pharmacologic Agents on Reentrant Atrial Flutter

126.               Atrioventricular Conduction During Flutter

127.               SUMMARY

128.               Chapter 9 Preexcitation Syndromes

129.               ATRIOVENTRICULAR BYPASS TRACTS

130.               ELECTROPHYSIOLOGIC PROPERTIES OF A-V BYPASS TRACTS

131.               ELECTROPHYSIOLOGIC EVALUATION IN PATIENTS WITH WOLFF–PARKINSON–WHITE SYNDROME

132.               Diagnosis of an A-V Bypass Tract

133.               MODE OF INITIATION OF TACHYCARDIAS

134.               ORTHODROMIC TACHYCARDIA

135.               PREEXCITED TACHYCARDIAS

136.               ATRIAL FIBRILLATION

137.               LOCALIZATION OF THE BYPASS TRACT

138.               RELATION OF LOCAL VENTRICULAR ELECTROGRAMS TO DELTA WAVE

139.               PACING FROM MULTIPLE ATRIAL SITES

140.               RETROGRADE ATRIAL ACTIVATION

141.               EFFECT OF BUNDLE BRANCH BLOCK DURING ORTHODROMIC TACHYCARDIA

142.               DIRECT RECORDING OF BYPASS TRACT POTENTIALS

143.               ROLE OF THE BYPASS TRACT IN GENESIS OF ARRHYTHMIAS

144.               DETERMINATION OF THE ANTEGRADE REFRACTORY PERIOD OF THE BYPASS TRACT

145.               INTERMITTENT PREEXCITATION

146.               EFFECT OF ANTIARRHYTHMIC AGENTS ON PREEXCITATION

147.               EXERCISE TESTING IN WOLFF–PARKINSON–WHITE SYNDROME

148.               DETERMINATION OF THE ANTEGRADE REFRACTORY PERIOD OF THE BYPASS TRACT BY PROGRAMMED STIMULATION

149.               TERMINATION OF ORTHODROMIC TACHYCARDIA

150.               MULTIPLE BYPASS TRACTS

151.               ATRIOVENTRICULAR NODAL “BYPASS TRACTS”—THE LOWN–GANONG–LEVINE SYNDROME

152.               Electrophysiologic Properties

153.               Atrial Pacing

154.               Response to Atrial Premature Depolarizations

155.               Ventriculoatrial Conduction

156.               Response to Pharmacologic and Physiologic Maneuvers

157.               Role of the Bypass Tract in Arrhythmias

158.               Therapeutic Implications

159.               ACCESSORY PATHWAYS WITH ANTEROGRADE DECREMENTAL CONDUCTION AND FASCICULOVENTRICULAR PATHWAYS

160.               Slowly Conducting Accessory Pathways

161.               Electrophysiologic Manifestations

162.               Atriofascicular and Long Atrioventricular Bypass Tracts

163.               Short Slowly Conducting Atrioventricular Bypass Tracts

164.               Nodofascicular and Nodoventricular Bypass Tracts

165.               Tachycardias Associated With Atriofascicular, Slowly Conducting A-V, Nodofascicular, and Nodoventricular Bypass Tracts

166.               Therapeutic Implications

167.               Fasciculoventricular Bypass Tracts

168.               Chapter 10 Recurrent Ventricular Tachycardia

169.               DEFINITIONS OF VENTRICULAR TACHYCARDIAS

170.               Morphology

171.               Duration

172.               CLASSIFICATION OF VENTRICULAR TACHYCARDIA QRS COMPLEXES

173.               DIAGNOSIS OF VENTRICULAR TACHYCARDIA

174.               Use of His Bundle Recordings in Diagnosing Ventricular Tachycardia

175.               PATHOPHYSIOLOGIC SUBSTRATE FOR VENTRICULAR TACHYARRHYTHMIAS

176.               Anatomic Substrate

177.               Electrophysiologic Substrate

178.               MECHANISMS OF VENTRICULAR TACHYCARDIA

179.               Initiation of Ventricular Tachycardias

180.               Initiation of Sustained Uniform Ventricular Tachycardia

181.               Initiation of Polymorphic Ventricular Tachycardia–Ventricular Fibrillation

182.               Initiation of Monomorphic Nonsustained Ventricular Tachycardia

183.               Response of Sustained Uniform Ventricular Tachycardia to Stimulation

184.               Protocol for Stimulation During Sustained VT

185.               Response of Ventricular Tachycardia to Overdrive Pacing—Continuous Resetting (Entrainment)

186.               EFFECT OF DRUGS ON VENTRICULAR TACHYCARDIA

187.               LOCALIZATION OF THE SITE OF ORIGIN OF VENTRICULAR TACHYCARDIA

188.               General Methods of Catheter Mapping

189.               Relationship of Mapping Data to Heart Disease

190.               Sinus Rhythm Mapping

191.               Relationship of QRS Morphologies to Sites of Origin of Tachycardias

192.               Role of Pace Mapping in Determining the Site of Origin of Ventricular Tachycardia

193.               VENTRICULAR STIMULATION IN MISCELLANEOUS DISORDERS

194.               Chapter 11 Catheter and Surgical Ablation in the Therapy of Arrhythmias

195.               BIOPHYSICS OF CURRENT ABLATION TECHNIQUES

196.               Direct Current Ablation

197.               Irreversible Electroporation (Pulsed Electrical Field Ablation)

198.               Radiofrequency Energy

199.               Novel Concepts in RF ablation

200.               Laser Ablation

201.               Cryoablation

202.               Ultrasound

203.               CONTROL OF SUPRAVENTRICULAR ARRHYTHMIAS BY ABLATIVE TECHNIQUES

204.               Ablation of Atrioventricular Bypass Tracts and Variants of Preexcitation

205.               Localization of Bypass Tracts

206.               Catheter Ablation of Bypass Tracts

207.               Ablation of Preexcitation Variants

208.               Complications of Procedures

209.               Ablation of the A-V Junction for Ventricular Rate Control During Atrial Tachyarrhythmias

210.               Catheter Ablation Techniques to Treat A-V Nodal Tachycardia

211.               SURGICAL AND CATHETER ABLATION TECHNIQUES TO MANAGE OTHER ATRIAL ARRHYTHMIAS

212.               Ablation of Atrial Tachycardia

213.               Ablation of Typical Atrial Flutter and Other Macroreentrant Atrial Arrhythmias

214.               SURGICAL AND CATHETER-BASED ABLATIVE TECHNIQUES FOR TREATMENT OF ATRIAL FIBRILLATION

215.               Role of Linear Lesions to the Atrial Roof and/or Mitral Annulus

216.               Ablation of Complex Fractionated Electrograms

217.               Stepwise Ablation (Ablation to Termination of Persistent AF)

218.               Additional Ablation After PVI

219.               Surgical Ablation of Atrial Fibrillation

220.               CONTROL OF VENTRICULAR ARRHYTHMIAS BY ABLATIVE TECHNIQUES

221.               Role of the ECG in Localization of Tachycardias

222.               Mapping Techniques for Ventricular Tachycardia

223.               Catheter Ablation of Ventricular Tachycardia Associated With Coronary Artery Disease

224.               Role of Catheter Ablation in the Treatment of Ventricular Tachycardia Associated With Nonischemic Left Ventricular Cardiomyopathy

225.               Role of Catheter Ablation in the Treatment of Ventricular Tachycardia Associated With Right Ventricular Cardiomyopathy

226.               The Role of Catheter Mapping and Ablation of Idiopathic Ventricular Tachycardias

227.               Catheter Ablation of Miscellaneous Ventricular Tachycardias

228.               Intraoperative Mapping and Surgical Ablation of Ventricular Tachycardias

229.               Intraoperative Mapping Techniques for Ventricular Tachycardia

230.               Surgical Treatment for Ventricular Tachyarrhythmias

231.               Results of Surgery

232.               Ventricular Tachycardia Unassociated With Coronary Artery Disease

233.               CONCLUSION

234.               Index

 

An aparitie	25 Aug. 2020
Autor	Dr. David Callans
Dimensiuni	22.1 x 3.3 x 28.19 cm
Editura	LWW
Format	Hardcover
ISBN	9781975115562
Limba	Engleza
Nr pag	850
Versiune digitala	DA